David Sinclair· PhD
And so that's the reason why it may be that NMN is at the sweet spot of the right size, but also has the right components to make just the right amount of NAD.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And so that's the reason why it may be that NMN is at the sweet spot of the right size, but also has the right components to make just the right amount of NAD.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Technically uh NMN is you can argue whether it's a precursor. It's sort of a precursor of NR, which is a precursor to cellular NAD. But again, NMN breaks down to NR and then that gets into cells and becomes NMN and NAD.